PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules

Core Viewpoint - PMGC Holdings Inc. has entered into a definitive agreement for a registered direct offering of 294,450 shares at a price of $5.04 per share, expected to raise approximately $1.48 million in gross proceeds [1][2]. Group 1: Offering Details - The offering involves the sale of common stock or pre-funded warrants, with the purchase price for the pre-funded warrants being the same as the shares, minus an exercise price of $0.001 per share [1]. - The transaction is anticipated to close on or about March 24, 2025, pending customary closing conditions [2]. - The company will have approximately 872,411 shares of common stock issued and outstanding following the offering [1]. Group 2: Regulatory Information - The offering is conducted under a shelf registration statement on Form S-3, which was declared effective by the SEC on February 7, 2025 [3]. - A final prospectus supplement and accompanying prospectus will be filed with the SEC, detailing the terms of the offering [3]. Group 3: Company Overview - PMGC Holdings Inc. is a diversified holding company that manages a portfolio through strategic acquisitions and investments across various industries [5]. - The company's portfolio includes three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC [5].